1. Salvage regimens using conventional chemotherapy agents for relapsed/refractory adult AML patients: a systematic literature review

   • Juan Eduardo Megías-Vericat
   • David Martínez-Cuadrón
   • Pau Montesinos

   Review Article 21 April 2018 Pages: 1115 - 1153

   

2. Role of minimal residual disease in the management of acute myeloid leukemia—a case-based discussion

   • A. Coltoff
   • J. Houldsworth
   • John Mascarenhas

   Review Article 27 April 2018 Pages: 1155 - 1167

3. Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia

   • Despina Piatopoulou
   • Margaritis Avgeris
   • Andreas Scorilas

   Original Article 20 March 2018 Pages: 1169 - 1182

   

4. Association of bone marrow fibrosis with inferior survival outcomes in chronic myelomonocytic leukemia

   • Maliha Khan
   • Tariq Muzzafar
   • Zeev Estrov

   Original Article 20 March 2018 Pages: 1183 - 1191

   

5. Elevated expression of the EZH2 gene in CALR-mutated patients with primary myelofibrosis

   • Ni Fan
   • Yigui Tang
   • Xinju Zhang

   Original Article 20 March 2018 Pages: 1193 - 1208

   

6. Treatment of late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: the role of corticosteroids

   • Xiao-Dong Mo
   • Xiao-Hui Zhang
   • Xiao-Jun Huang

   Original Article 12 March 2018 Pages: 1209 - 1217

   

7. Lymphoma-like monoclonal B cell lymphocytosis in a patient population: biology, natural evolution, and differences from CLL-like clones

   • Sam Vander Meeren
   • Bert Heyrman
   • Kristin Jochmans

   Original Article 28 February 2018 Pages: 1219 - 1227

   

8. Survival analysis of patients with Hodgkin lymphoma who failed high dose chemotherapy and autologous stem cell transplant

   • Mahmoud A. Elshenawy
   • M. Shahzad Rauf
   • Saad Akhtar

   Original Article 26 February 2018 Pages: 1229 - 1240

   

9. The impact of stem cell transplantation on the natural course of peripheral T-cell lymphoma: a real-world experience

   • Sarah Rohlfing
   • Sascha Dietrich
   • Peter Dreger

   Original Article 16 March 2018 Pages: 1241 - 1250

   

10. Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma

    • Vanessa Desantis
    • Maria Antonia Frassanito
    • Domenico Ribatti

    Original Article 28 March 2018 Pages: 1251 - 1258

    

11. Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw

    • Caterina Musolino
    • Giacomo Oteri
    • Salvatore Campo

    Original Article 15 March 2018 Pages: 1259 - 1269

12. Consensus statement for cancer patients requiring intensive care support

    • M. G. Kiehl
    • G. Beutel
    • Consensus of the German Society of Hematology and Medical Oncology (DGHO), Austrian Society of Hematology and Oncology (OeGHO), German Society for Medical Intensive Care Medicine and Emergency Medicine (DGIIN), and Austrian Society of Medical and General Intensive Care and Emergency Medicine (ÖGIAIN)

    Original Article Open access 27 April 2018 Pages: 1271 - 1282

13. Unmet supportive care needs of haematological cancer survivors: rural versus urban residents

    • Flora Tzelepis
    • Christine L. Paul
    • Anna Williamson

    Original Article 10 March 2018 Pages: 1283 - 1292

14. Higher Sclerostin/SOST expression is associated with lower percentage of circulatory blasts and better prognosis in patients with myelofibrosis

    • Marko Lucijanic
    • Ana Livun
    • Rajko Kusec

    Letter to the Editor 12 March 2018 Pages: 1293 - 1294

    

15. Langerhans cell histiocytosis and primary hemophagocytic lymphohistiocytosis with persistent clonal T-large granular lymphocyte proliferation

    • Süreyya Savaşan
    • Janet Poulik
    • Ali Gabali

    Letter to the Editor 26 March 2018 Pages: 1295 - 1296

    

16. Histological transformation of MALT lymphoma to plasma cell leukemia after rituximab-containing therapy

    • Yutaro Suzuki
    • Akira Honda
    • Mineo Kurokawa

    Letter to the Editor 26 March 2018 Pages: 1297 - 1298

    

17. Correction to: MYC-dependent downregulation of telomerase by FLT3 inhibitors is required for their therapeutic efficacy on acute myeloid leukemia

    • Xiaolu Zhang
    • Bingnan Li
    • Dawei Xu

    Correction 25 April 2018 Pages: 1299 - 1299